Sponsored by Legends Media*

TODAY’S TOP ALERT! 

Nasdaq: TNFA

Hey Folks!

Nvidia has stolen the headlines this morning — and not for a huge earnings beat that still didn’t satisfy investors…

No, this time Chinese regulators are taking aim at it for potential violations of the country’s antimonopoly law.

Predictably, NVDA is down and dragging other major tech stocks and the broader indexes down with it.

I think it is creating some great buying opportunities today if you have been with me in the live chat room.

Across the board, big-name stocks are bleeding, but if you caught my dispatch this morning (and I hope you did!), you’ve had the chance to watch some incredible price action…

I brought a small-cap pharma stock to your attention, which was “one of the best setups I’m seeing.”

My favorite trading algo lit up on Friday with multiple “GO” signals but the stock had yet to take off…

Still, it was up in the pre-market, which told me it could be “primed for liftoff 🚀.”

As of this writing, here’s what we’re looking at (though we already saw a 30% gain on the day, but who’s counting?!)

That looks like liftoff to me!

It helps that the company announced that “significant positive topline results from a Phase 2a study of its lead drug candidate MYMD-1® (isomyosamine) was presented at a prestigious international congress of global experts in sarcopenia and related disorders held December 6–8, 2024 in Washington, D.C.”

Also in the press release, TNFA CEO Mitchell Glass revealed that “Based on the positive results from our MYMD-1 Phase 2a study, we are set to launch a Phase 2b study in sarcopenia/frailty early in the first quarter of 2025.”

Evidently, “Subjects in the trial who were given once daily oral doses of MYMD-1 showed significant decreases in several biomarkers attributed to chronic inflammation.”

If you saw my earlier message, you know that MYMD-1 is TNFA’s lead candidate, so it’s no surprise the stock is responding so well to the news, especially considering the technical setup already in place from last week.

I won’t be surprised if this rally continues through the day and into the week, so be sure to stay tuned to TNFA as it develops!

To Your Success,

Jeff Bishop

P.S.  The best way to get all the details right away when I have a new trade coming up is to make sure you are a member of my MOBILE ALERTS list.

All you need to do is whip out your phone and text the word:

  “RAGE” to 1- (888) 404-5747 📲

Then, you can be near the first in line when I have a hot new idea that drops (like today!)

Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull

*Just so you know, what you're reading is curated content for which we have received a monetary fee (detailed below) to create and distribute. Let's be clear that investing can be quite the roller coaster as stock prices can have wild swings up and down, so consider those crucial risks before you ever consider trading anything we discuss. Make sure you check out our full disclosure down below for the details on how we were paid, the risks, and why these results aren't what you'd call “typical.”

Just a quick heads up about this ad you're reading—as we’ve said, even though we like the company referenced above, and all the facts we discussed above are true to the best of our knowledge, we are running a business here. To distribute this information and help offset the costs of maintaining our large digital audience, in advance of writing the content above, we received twenty five thousand dollars (cash) from Legends Media for advertising TNF Pharmaceuticals, Inc for a one day marketing program on December 9, 2024. This was paid by someone else not connected to TNF Pharmaceuticals, Inc. It might be obvious, but whoever paid for this might own shares and is likely looking to sell some or all of them at any time after we send out this information, which might affect the stock price. We may also buy or sell shares in the company at some point in the future, although neither RagingBull nor its owners own any shares of the company at this time. Also, keep in mind that due to the sheer size of our audience, if even a small percentage of people decide they want to buy this stock, it could potentially boost interest enough to hike up those share prices and cause a temporary spike, and the opposite is possible as our program ends, though that is not always the case.

Now, diving right into TNF Pharmaceuticals, Inc might sound exciting. But remember, it’s like venturing into the wilderness—be aware that there's exceptional risk involved in trading. This isn't small potatoes we're talking about; you could lose every dime you put in, so always carefully think about what you’re doing. That’s why they call this trading, after all. We're shining a light on the good stuff about the company here, but it's on you to do your homework, make your own calls, and determine a plan for your own trading, hopefully with the help of your professional 1nvestment advis0r.

Oh, that brings us to another crucial point—we're not here to tell you (or even recommend) what you should do with your hard-earned money. We’re simply sharing our non-expert thoughts by highlighting some companies we like that could use some help telling their story to more people. We’re obviously biased in our writing. We’re not here to dig into anything that may be negative about the company; this is advertising, after all! Also, keep in mind that if we make some predictions about the future, these are technically known as “forward-L00king statements” under the securities acts, so take those with a grain of salt. As with all forecasts, they’re not set in stone, often wrong, and we certainly can’t know where the Company’s earnings, business, or share price will be tomorrow or a year from now.

Everything you read from us is all for your education, information, and possible entertainment. While we believe the info is reliable and accurate, we can't wear a cape and guarantee it. Before you jump into anything, make sure to talk it over with a pro—someone you trust who's licensed to give you real advice. To be clear, 

Neither Raging Bull nor its owners, employees, or independent contractors are registered as a secur1.ties br0ker-deale.r, br0ker, 1nvest.ment advis0r (IA), or IA rep’s with the SEC, any state securities regulat0ry auth.ority, or any self-regulat0ry organization.

So, that's the scoop! If you're intrigued and want to learn more about the companies we talk about, hit up the SEC's website to dig into their filings and see the full picture.